You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Approach to Management of Keloids

Fred J. Stucker, MD; Gary Y. Shaw, MD

Arch Otolaryngol Head Neck Surg. 1992;118(1):63-67.


Abstract

• Keloids present a major therapeutic dilemma for the surgeon because of frequent recurrences. We use a new protocol for management of large primary or recalcitrant keloids. The technique employs carbon dioxide laser resection of the keloid and then allows the open wound bed to heal by secondary intention. The open wound is treated as though it were a third-degree skin burn. The wounds invariably orient their long axis parallel to the relaxed skin tension lines. No keloid has ever been noted to recur before epithelial migration is complete. Careful follow-up detects early recurrences that are then treated with injection consisting of 40 mg/mL of triamcinolone acetonid (Kenalog), 150 mg of hyaluronidase (Wydase), and 2% lidocaine via a dermajet. Thirty-seven patients were treated with this protocol and have been followed up for at least 2 years. A control rate of 84% has been achieved with compliant patients.

(Arch Otolaryngol Head Neck Surg. 1992;118:63-67)



Author Affiliations

From the Department of Otolaryngology—Head and Neck Surgery, Louisiana State University Medical Center, Shreveport.


Footnotes

Accepted for publication July 19, 1991.

Presented at the American Academy of Facial Plastic and Reconstructive Surgery meeting, Houston, Tex, February, 1991.

Reprint requests to the Department of Otolaryngology—Head and Neck Surgery, Louisiana State University Medical Center, PO Box 33932, Shreveport, LA 71130 (Dr Stucker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical Mitomycin C in the Prevention of Keloid Scar Recurrence
Sanders et al.
Arch Facial Plast Surg 2005;7:172-175.
ABSTRACT | FULL TEXT  

Cultured Epithelial Autografts in the Treatment of Extensive Recalcitrant Keloids
Haas and Reilly
Arch Dermatol 1998;134:549-552.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.